A Multicenter Retrospective Study of Vancomycin Dosing by Weight Measures in Children.


Journal

Hospital pediatrics
ISSN: 2154-1671
Titre abrégé: Hosp Pediatr
Pays: United States
ID NLM: 101585349

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 15 10 2021
medline: 27 1 2022
entrez: 14 10 2021
Statut: ppublish

Résumé

Vancomycin carries risks of treatment failure and emergent resistance with underexposure and renal toxicity with overexposure. Children with overweight or obesity may have altered pharmacokinetics. We aimed to examine how body weight metrics influence vancomycin serum concentrations and to evaluate alternative dosing strategies. This was a multicenter retrospective cohort study across 3 large, academic hospitals. Patients aged 2 to 18 years old who received ≥3 doses of intravenous vancomycin were included. Weight metrics included total body weight, adjusted body weight, ideal body weight, body surface area, and allometric weight. Outcomes included vancomycin concentration and ratios of area under the curve (AUC) to minimum inhibitory concentration (MIC). Regression analyses were used to examine which body-weight identifier predicted outcomes. Of the 1099 children, 45% were girls, mean age was 9.0 (SD = 5.4) years, 14% had overweight, and 17% had obesity. Seventy-five percent of children had vancomycin concentrations in the subtherapeutic range by trough <10 µg/mL, and 63% had a ratio of AUC to MIC <400 μg-hr/mL. Three percent had a supratherapeutic initial trough >20 µg/mL or ratio of AUC to MIC >600 μg-hr/mL. Serum vancomycin concentrations were higher in children with overweight or obesity compared with children who were at a normal weight or underweight; the mean ratio of AUC to MIC also trended higher in the groups with overweight or obesity. Most children received vancomycin regimens that produced suboptimal trough levels. Children with overweight or obesity experienced higher vancomycin trough levels than children of normal weight despite receiving lower total body weight dosing. Using the ratio of AUC to MIC was a better measure of drug exposure.

Identifiants

pubmed: 34645692
pii: hpeds.2020-004465
doi: 10.1542/hpeds.2020-004465
doi:

Substances chimiques

Anti-Bacterial Agents 0
Vancomycin 6Q205EH1VU

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e289-e296

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK109199
Pays : United States

Informations de copyright

Copyright © 2021 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest relevant to this article to disclose.

Auteurs

Manaswitha Khare (M)

Department of Pediatrics, School of Medicine, University of California, San Diego, San Diego, California.

Meredith B Haag (MB)

Department of Pediatrics, Oregon Health and Science University and Doernbecher Children's Hospital, Portland, Oregon.

Garrett Kneese (G)

Department of Pediatrics, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas.

Jared P Austin (JP)

Department of Pediatrics, Oregon Health and Science University and Doernbecher Children's Hospital, Portland, Oregon.

Jeremy Perlman (J)

Department of Pediatrics, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas.

Aniqa Azim (A)

Department of Pediatrics, Oregon Health and Science University and Doernbecher Children's Hospital, Portland, Oregon.

Carisse Orsi (C)

Department of Pediatrics, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas.

Byron A Foster (BA)

Department of Pediatrics, Oregon Health and Science University and Doernbecher Children's Hospital, Portland, Oregon fosterb@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH